Structural insights into substrate traffic and inhibition in acetylcholinesterase

Acetylcholinesterase (AChE) terminates nerve‐impulse transmission at cholinergic synapses by rapid hydrolysis of the neurotransmitter, acetylcholine. Substrate traffic in AChE involves at least two binding sites, the catalytic and peripheral anionic sites, which have been suggested to be allosterically related and involved in substrate inhibition. Here, we present the crystal structures of Torpedo californica AChE complexed with the substrate acetylthiocholine, the product thiocholine and a nonhydrolysable substrate analogue. These structures provide a series of static snapshots of the substrate en route to the active site and identify, for the first time, binding of substrate and product at both the peripheral and active sites. Furthermore, they provide structural insight into substrate inhibition in AChE at two different substrate concentrations. Our structural data indicate that substrate inhibition at moderate substrate concentration is due to choline exit being hindered by a substrate molecule bound at the peripheral site. At the higher concentration, substrate inhibition arises from prevention of exit of acetate due to binding of two substrate molecules within the active‐site gorge.

[1]  P. Masson,et al.  Two invertebrate acetylcholinesterases show activation followed by inhibition with substrate concentration. , 1998, The Biochemical journal.

[2]  K. Laidler,et al.  Molecular Mechanisms for Hydrolytic Enzyme Action , 1961, Nature.

[3]  Collaborative Computational,et al.  The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.

[4]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[5]  W. Delano The PyMOL Molecular Graphics System , 2002 .

[6]  T. Rosenberry,et al.  A steric blockade model for inhibition of acetylcholinesterase by peripheral site ligands and substrate. , 1999, Chemico-biological interactions.

[7]  P. Taylor,et al.  Acetylcholinesterase inhibition by fasciculin: Crystal structure of the complex , 1995, Cell.

[8]  J L Sussman,et al.  Purification and crystallization of a dimeric form of acetylcholinesterase from Torpedo californica subsequent to solubilization with phosphatidylinositol-specific phospholipase C. , 1988, Journal of molecular biology.

[9]  G. Murshudov,et al.  Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.

[10]  이기용 백미의 acetylcholinesterase 저해 활성 성분 , 2001 .

[11]  T. Rosenberry,et al.  Nonequilibrium analysis alters the mechanistic interpretation of inhibition of acetylcholinesterase by peripheral site ligands. , 1998, Biochemistry.

[12]  J. Mccammon,et al.  Electrostatic Influence on the Kinetics of Ligand Binding to Acetylcholinesterase , 1997, The Journal of Biological Chemistry.

[13]  J. Sussman,et al.  Structure of a complex of the potent and specific inhibitor BW284C51 with Torpedo californica acetylcholinesterase. , 2002, Acta crystallographica. Section D, Biological crystallography.

[14]  W. Kloot,et al.  Vesicle size and transmitter release at the frog neuromuscular junction when quantal acetylcholine content is increased or decreased , 2002, The Journal of physiology.

[15]  P Taylor,et al.  Interaction of fluorescence probes with acetylcholinesterase. The site and specificity of propidium binding. , 1975, Biochemistry.

[16]  N. Ariel,et al.  Acetylcholinesterase peripheral anionic site degeneracy conferred by amino acid arrays sharing a common core. , 1994, The Journal of biological chemistry.

[17]  J. Changeux,et al.  Responses of acetylcholinesterase from Torpedo marmorata to salts and curarizing drugs. , 1966, Molecular pharmacology.

[18]  I B WILSON,et al.  The inhibitory effect of stilbamidine, curare and related compounds and its relationship to the active groups of acetylcholine esterase; action of stilbamidine upon nerve impulse conduction. , 1950, Biochimica et biophysica acta.

[19]  R. M. Krupka,et al.  Molecular Mechanisms for Hydrolytic Enzyme Action. II. Inhibition of Acetyl-cholinesterase by Excess Substrate , 1961 .

[20]  Jean-Louis Marty,et al.  Biosensor for detection of organophosphate and carbamate insecticides , 1992 .

[21]  J. Sussman,et al.  Crystal structures of aged phosphonylated acetylcholinesterase: nerve agent reaction products at the atomic level. , 1999, Biochemistry.

[22]  K. Augustinsson,et al.  A mechanistic model for butyrylcholinesterase. , 1979, Biochimica et biophysica acta.

[23]  J. Sussman,et al.  Histochemical method for characterization of enzyme crystals: application to crystals of Torpedo californica acetylcholinesterase. , 2001, Acta crystallographica. Section D, Biological crystallography.

[24]  G J Kleywegt,et al.  Detection, delineation, measurement and display of cavities in macromolecular structures. , 1994, Acta crystallographica. Section D, Biological crystallography.

[25]  P. Taylor,et al.  Expression of recombinant acetylcholinesterase in a baculovirus system: kinetic properties of glutamate 199 mutants. , 1992, Biochemistry.

[26]  S. Lifson,et al.  External and internal electrostatic potentials of cholinesterase models. , 1997, Journal of molecular graphics & modelling.

[27]  C. Deane,et al.  Carbonyl-carbonyl interactions stabilize the partially allowed Ramachandran conformations of asparagine and aspartic acid. , 1999, Protein engineering.

[28]  R J Read,et al.  Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.

[29]  J. Sussman,et al.  The X-ray structure of a transition state analog complex reveals the molecular origins of the catalytic power and substrate specificity of acetylcholinesterase. , 1996 .

[30]  M. Davies,et al.  Unmasking tandem site interaction in human acetylcholinesterase. Substrate activation with a cationic acetanilide substrate. , 2003, Biochemistry.

[31]  B. Roufogalis,et al.  Relative binding sites of pharmacologically active ligands on bovine erythrocyte acetylcholinesterase. , 1972, Molecular Pharmacology.

[32]  J. Czaplicki,et al.  Involvement of Deacylation in Activation of Substrate Hydrolysis by Drosophila Acetylcholinesterase* , 2001, The Journal of Biological Chemistry.

[33]  A. Eastman,et al.  Apoptosis in an Interleukin-2-dependent Cytotoxic T Lymphocyte Cell Line Is Associated with Intracellular Acidification , 1995, The Journal of Biological Chemistry.

[34]  H. R. Smissaert Cholinesterase Inhibition in Spider Mites Susceptible and Resistant to Organophosphate , 1964, Science.

[35]  M. Froment,et al.  Asp7O in the peripheral anionic site of human butyrylcholinesterase. , 1996, European journal of biochemistry.

[36]  B. Belleau,et al.  Kinetic effects of leptocurares and pachycurares on the methanesulfonylation of acetylcholinesterase. A correlation with pharmacodynamic properties. , 1970, Molecular pharmacology.

[37]  A. Goldman,et al.  Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein , 1991, Science.

[38]  J. Sussman,et al.  Differential effects of "peripheral" site ligands on Torpedo and chicken acetylcholinesterase. , 1994, Molecular pharmacology.

[39]  J. Colletier,et al.  Inhibition of Drosophila melanogaster acetylcholinesterase by high concentrations of substrate. , 2004, European journal of biochemistry.

[40]  D. Quinn,et al.  Acetylcholinesterase: enzyme structure, reaction dynamics, and virtual transition states , 1987 .

[41]  J L Sussman,et al.  Three‐dimensional structures of Drosophila melanogaster acetylcholinesterase and of its complexes with two potent inhibitors , 2000, Protein science : a publication of the Protein Society.

[42]  D. Bohme,et al.  Bridging the Gap between the Gas Phase and Solution: Transition in the Kinetics of Nucleophilic Displacement Reactions , 1981 .

[43]  P. Waser,et al.  Interaction of quaternary ammonium compounds with acetylcholinesterase: characterization of the active site. , 1989, European journal of pharmacology.

[44]  Kevin Cowtan,et al.  research papers Acta Crystallographica Section D Biological , 2005 .

[45]  Yvain Nicolet,et al.  Crystal Structure of Human Butyrylcholinesterase and of Its Complexes with Substrate and Products* , 2003, Journal of Biological Chemistry.

[46]  P. Taylor,et al.  Role of the peripheral anionic site on acetylcholinesterase: inhibition by substrates and coumarin derivatives. , 1991, Molecular pharmacology.

[47]  Irwin B. Wilson Mechanism of hydrolysis. II. New evidence for an acylated enzyme as intermediate. , 1951, Biochimica et biophysica acta.

[48]  William L. Jorgensen,et al.  Ab initio and Monte Carlo calculations for a nucleophilic addition reaction in the gas phase and in aqueous solution , 1986 .

[49]  J. Sussman,et al.  Acetylcholinesterase: 'classical' and 'non-classical' functions and pharmacology. , 2005, Current opinion in pharmacology.

[50]  G. Kleywegt,et al.  Crystal structure of an acetylcholinesterase-fasciculin complex: interaction of a three-fingered toxin from snake venom with its target. , 1995, Structure.

[51]  J. Sussman,et al.  Acetylcholinesterase , 2007, Journal of Molecular Neuroscience.

[52]  G. Alles,et al.  CHOLINESTERASES IN THE BLOOD OF MAN , 1940 .

[53]  Frank H. Allen,et al.  Carbonyl-carbonyl interactions can be competitive with hydrogen bonds , 1998 .

[54]  A. W. Schüttelkopf,et al.  PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. , 2004, Acta crystallographica. Section D, Biological crystallography.

[55]  T L Rosenberry,et al.  Fasciculin 2 Binds to the Peripheral Site on Acetylcholinesterase and Inhibits Substrate Hydrolysis by Slowing a Step Involving Proton Transfer during Enzyme Acylation (*) , 1995, The Journal of Biological Chemistry.

[56]  T. Bartol,et al.  Miniature endplate current rise times less than 100 microseconds from improved dual recordings can be modeled with passive acetylcholine diffusion from a synaptic vesicle. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[57]  N. Ariel,et al.  Structures of recombinant native and E202Q mutant human acetylcholinesterase complexed with the snake-venom toxin fasciculin-II. , 2000, Acta crystallographica. Section D, Biological crystallography.

[58]  J. Sussman,et al.  An electrostatic mechanism for substrate guidance down the aromatic gorge of acetylcholinesterase. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[59]  K. Courtney,et al.  A new and rapid colorimetric determination of acetylcholinesterase activity. , 1961, Biochemical pharmacology.

[60]  J. Sussman,et al.  Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[61]  N. Ariel,et al.  Substrate inhibition of acetylcholinesterase: residues affecting signal transduction from the surface to the catalytic center. , 1992, The EMBO journal.

[62]  P. Taylor,et al.  Mutagenesis of essential functional residues in acetylcholinesterase. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[63]  Zoran Radić,et al.  Structural insights into ligand interactions at the acetylcholinesterase peripheral anionic site , 2003, The EMBO journal.

[64]  P. Taylor,et al.  Site of fasciculin interaction with acetylcholinesterase. , 1994, The Journal of biological chemistry.

[65]  R. M. Krupka,et al.  Molecular Mechanisms for Hydrolytic Enzyme Action. I. Apparent Non-competitive Inhibition, with Special Reference to Acetylcholinesterase , 1961 .

[66]  Wolfgang Kabsch,et al.  Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants , 1993 .